AurKa Pharma

AurKa Pharma Inc. is an anti-tumor drug developer. The company has developed Aurora kinase A (Aurora kinase A) inhibitor AK-01, which is currently in Phase 1 clinical trials and is expected to become a "first-in-class" therapy for various types of solid tumors.